NCT06755762
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Circulating Tumor Cell, +12 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
Clinical trial condition
HNSCC
Explore clinical trials studying HNSCC. Study availability and eligibility vary by location and protocol.
78 public trials
37 recruiting studies
HNSCC trial results
NCT05877430
- Conditions
- Advanced Cancer, Advanced Solid Tumor, Carcinoma, +23 more
- Locations
-
- University of California, Irvine Irvine, California, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Samsung Medical Center Seoul, South Korea
- Severance Hospital Seoul, South Korea
NCT06741982
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Recruiting
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
NCT06259552
- Conditions
- CRC, Carcinoma, Carcinoma, Squamous Cell, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT05192655
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
- Locations
-
- Department of Radiooncology and Radiotherapy, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany
NCT05980702
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +11 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China
NCT05980715
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China
NCT07814248
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +45 more
- Locations
-
Not specified
Not yet recruiting
Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07778732
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
- Locations
-
Not specified
Not yet recruiting
Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT07741565
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +12 more
- Locations
-
Not specified